Amplification with molecular beacon primers and reverse line blotting for the detection and typing of human papillomaviruses

Journal of Virological Methods

Volumn 89, Issue 1-2, 2000, Pages 29-37

  Jordens, J Zoe ^a,b   Lanham, S ^a   Pickett, M A ^a   Amarasekara, Shamila ^a   Abeywickrema, Iyanthimala ^c   Watt, P J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c National STD/AIDS Control Programme   (Sri Lanka)

Author keywords

Human papillomavirus; Line blotting; Molecular beacon primer; Sequence detector system

Indexed keywords

VIRUS DNA;

ARTICLE; DNA SEQUENCE; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; VIRUS CARCINOGENESIS; VIRUS CHARACTERIZATION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

ADULT; COMPARATIVE STUDY; DNA PRIMERS; FEMALE; GENOTYPE; HUMAN; PAPILLOMAVIRUS, HUMAN; PAPOVAVIRIDAE INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; VAGINAL SMEARS;

EID: 0033834114     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(00)00195-6     Document Type: Article

References (18)

1. Becker T.M., Wheeler C.M., McGough N.S., Parmenter C.A., Jordan S.W., Stidley C.A., McPherson R.S., Dorin M.H. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. J. Am. Med. Assoc. 271:1994;1181-1187.
2. Cuzick J., Szarewski A., Terry G. Human papillomavirus testing in primary cervical screening. Lancet. 345:1995;1533-1536.
3. Cuzick J., Meijer C.J.L.M., Walboomers J.M.M. Screening for cervical cancer. Lancet. 351:1998;1439-1440.
4. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76:1995;1057-1062.
5. Fricker J. Cervical-cancer screening comes of age-or does it? Lancet. 350:1997;1010.
6. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., Schiffman M.H., Scott D.R., Apple R.J. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38:2000;357-361.
7. Gravitt P.E., Peyton C.L., Apple R.J., Wheeler C.M. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 36:1998;3020-3027.
8. Hildeshein A., Schiffman M.H., Gravitt P.E., Glass A.G., Greer C.E., Zhang T., Scott D.R., Rush B.B., Lawler P., Sherman M.E., Kurman R.J., Manos M.M. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169:1994;235-240.
9. Jacobs M.V., de Roda Husman A.M., van den Brule A.J.C., Snijders P.J.F., Meijer C.J.L.M., Walboomers J.M.M. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J. Clin. Microbiol. 33:1995;901-905.
10. Josefsson A., Livak K., Gyllensten U. Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay. J. Clin. Microbiol. 37:1999;490-496.
11. Kalantari M., Karlsen F., Johansson B., Sigurjonsson T., Warleby B., Hagmar B. Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade. Human Pathol. 28:1997;899-904.
12. Kleter B., van Doorn L., ter Schegget J., Schrauwen L., van Krimpen K., Burger M., ter Harmsel B., Quint W. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am. J. Pathol. 153:1998;1731-1739.
13. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., Wolinsky S.M. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells. 7:1989;209-214.
14. Nandakumar A., Anantha N., Venugopal T.C. Incidence, mortality and survival in cancer of the cervix in Bangalore, India. Br. J. Cancer. 71:1995;1348-1352.
15. Nazarenko I.A., Bhatnagar S.K., Hohman R.J. A closed tube format for amplification and detection of DNA based on energy transfer. Nucl. Acids Res. 25:1997;2516-2521.
16. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y.F., Klein R.S., Burk R.D. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J. Clin. Microbiol. 35:1997;1304-1310.
17. van Ranst M.A., Tachezy R., Delius H., Burk R.D. Taxonomy of the human papillomaviruses. Papillomavirus Rep. 4:1993;61-65.
18. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J.F., Peto J., Meijer C.J.L.M., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:1999;12-19.